Products & ReviewLife Sciences
GENLISA™ Hamster Anti-SARS-CoV-2 IgG Antibody to Spike RBD protein Quantitative TITRATION ELISA
KRISHGEN BioSystemsKBBP01
ELISA for the quantitative determination of IgG Antibodies to SARS-CoV-2 (COVID-19) Spike RBD protein in Hamster serum.
This range of Hamster ELISA is currently being used for pre-clinical assessment and validation of vaccines against SARS-CoV-2 including:
- Selection of a novel candidate
- Immunization studies
- Titration of antibodies – toxicology
- Other in-vitro studies
These specifically designed ELISA can be used for different kinds of vaccines being developed in the industry - specific for S1, S2 or RBD; both mRNA based, and DNA based.
About the SARS-CoV-2 Hamster IgG to Spike RBD Assay:
- Based on monoclonal antibody detection for better sensitivity. A sandwich ELISA design and highly specific antibodies (rated highly specific in a study done by PATH) allow for a robust ELISA with low cross reactivity
- Standard, ready-to-use protocol
- The option to run serum or plasma samples
- In stock, ships in 2 days at ambient temperature
- Developed against seven-step validation process, as per ICH and FDA guidelines for biological assays.
- Calibrator Range: 0 ng/ml - 720 ng/ml
- Sensitivity: 12 ng/ml
- Reactivity: Hamster
- Shipping Condition: 2 - 8 Deg C
- Detection Method: Colorimetric
- Usage: For Research Use Only
- Research Area: COVID-19